[Editorial] A new vaccine for typhoid control

Last week, WHO announced prequalification of the first conjugate vaccine to prevent typhoid (Typbar TCV, manufactured by Bharat Biotech, India) after the publication of randomised controlled trials, including that by Celina Jin and colleagues in The Lancet on Sept 28, 2017. WHO has decided that Typbar TCV was successfully assessed for quality, safety, and efficacy, and it is now approved for distribution by UN agencies. Already in use in India and Nepal in babies older than 6 months, the vaccine is to be licensed for use in infants younger than 2 years.
Source: LANCET - Category: General Medicine Authors: Tags: Editorial Source Type: research